WeemsMF,UpadhyayK,SandhuHS, 2018.Survey of ECMO practices for infants with hypoxic ischemic encephalopathy,J Perinatol 38 1197 -204
ButtTK,FarooquiR,KhanMA, 2008.Risk factors for hypoxic ischemic encephalopathy in children,J Coll Physicians Surg Pak 18 428 -32
ItooBA,Al-HawsawiZM,KhanAH, 2003.Hypoxic ischemic encephalopathy. Incidence and risk factors in North Western Saudi Arabia,Saudi Med J 24 147 -53
MartinelloK,HartAR,YapS,MitraS,RobertsonNJ, 2017.Management and investigation of neonatal encephalopathy: 2017 update,Arch Dis Child Fetal Neonatal Ed 102 F346 -58
ChalakL,LatremouilleS,MirI,SánchezPJ,Sant'Anna G, 2018.A review of the conundrum of mild hypoxic-ischemic encephalopathy: Current challenges and moving forward,Early Hum Dev 120 88 -94
AhmadQM,ChishtiAL,WaseemN., 2018.Role of melatonin in management of hypoxic ischaemic encephalopathy in newborns: A randomized control trial,J Pak Med Assoc 68 1233 -7
ErtlM,WeberS,HammelG,SchroederC, 2018.Transorbital sonography for early prognostication of hypoxicischemic encephalopathy after cardiac arrest,J Neuroimaging 28 542 -8
LuJ,YaoXQ,LuoX,WangY,ChungSK,TangHX, 2017.Monosialoganglioside 1 may alleviate neurotoxicity induced by propofol combined with remifentanil in neural stem cells,Neural Regen Res 12 945 -52
LiS,XiaoN,ZhangX,LiuL,LinL,ChenS, 2008.Effects of exogenous ganglioside-1 on learning and memory in a neonatal rat model of hypoxia-ischemia brain injury,Neural Regen Res 3 1004 -9
CohenRA,BrowndykeJN,MoserDJ,PaulRH,GordonN,SweetL, 2003.Long-term citicoline (cytidine diphosphate choline) use in patients with vascular dementia: neuroimaging and neuropsychological outcomes,Cerebrovasc Dis 16 199 -204
ConantR,SchaussAG, 2004.Therapeutic applications of citicoline for stroke and cognitive dysfunction in the elderly: A review of the literature,Altern Med Rev 9 17 -31
GiménezR,SolerS,AguilarJ, 1999.Cytidine diphosphate choline administration activates brain cytidine triphosphate: phosphocholine cytidylytransferase in aged rats,Neurosci Lett 273 163 -6
SamsonJC., 1990.GM1 ganglioside treatment of central nervous system injury: Clinical evidence for improved recovery,Drug Develop Res 19 209 -24
Stephen D. Skaper , Alberta Leon, Gino,Toffano, 1989.Ganglioside function in the development and repair of the nervous system,Mol Neurobiol 3 173 -99
SkaperSD,LeonA, 1992.Monosialogangliosides, neuroprotection, and neuronal repair processes,J Neurotrauma 9 S507 -16
Abou-AbbassH,BahmadH,Abou-El-HassanH,ZhuR,ZhouS,DongX, 2016.Deciphering glycomics and neuroproteomic alterations in experimental traumatic brain injury: Comparative analysis of aspirin and clopidogrel treatment,Electrophoresis 37 1562 -76
ShengL,LiZ., 2017.Adjuvant treatment with monosialoganglioside may improve neurological outcomes in neonatal hypoxicischemic encephalopathy: A meta-analysis of randomized controlled trials,PloS One 12 e0183490 -
TracyCM,GrayAJ,CuéllarJ,ShawTS,HowlettAC,TaylorRM, 2014.Programmed cell death protein 5 interacts with the cytosolic chaperonin containing tailless complex polypeptide 1 (CCT) to regulate tubulin folding,J Biol Chem 289 4490 -502
FacciL,LeonA,SkaperSD, 1990.Hypoglycemic neurotoxicity in vitro: involvement of excitatory amino acid receptors and attenuation by monosialoganglioside GM1,Neuroscience 37 709 -16
OliveiraNK,FerreiraRN,LopesS,ChiariE,CamargosE,MartinelliPM, 2017.Cardiac autonomic denervation and expression of neurotrophins (NGFand BDNF) and their receptors during experimental chagas disease,Growth Factors 35 161 -70
GorriaM,HucL,SergentO,RebillardA,GaboriauF,Dimanche-BoitrelMT, 2006.Protective effect of monosialoganglioside gm1 against chemically induced apoptosis through targeting of mitochondrial function and iron transport,Biochem Pharmacol 72 1343 -53
SinghSK,DuaT,TandonA,KumariS,RayG,BatraS., 1999.Status of lipid peroxidation and antioxidant enzymes in hypoxic ischemic encephalopathy,Indian Pediatr 36 561 -6